Latigo Biotrapeutics position history
The shares of Latigo Biotrapeutics that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q3: 850,000 shares, $14M, 0.06% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|